Elizabeth F. Franklin and Tom Snow
May 30, 2025, 08:55
Elizabeth F. Franklin and Tom Snow on Sanofi’s Commitment to Patient-Centric Innovation in Oncology
Sanofi shared a post on LinkedIn:
“While important progress has been made in the treatment of multiple myeloma in recent years, we recognize there is still significant work to do to improve the lives of those living with this cancer.
Understanding and learning from multiple myeloma patients is a foundational part of our approach to advancing research for this difficult-to-treat cancer.
Read more from Elizabeth F. Franklin and Tom Snow on our commitment to patient-centric innovation in oncology.”
More posts featuring Sanofi on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06
Jun 2, 2025, 15:40
Jun 2, 2025, 15:37
Jun 2, 2025, 15:20